World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 20 August 2018
Main ID:  ISRCTN88839993
Date of registration: 30/11/2016
Prospective Registration: No
Primary sponsor: Stig & Ragna Gorthon Foundation
Public title: The presence of Candida albicans in breastmilk during the breastfeeding period
Scientific title: A case/control study of breastfeeding women with and without symptoms that are anecdotally related to thrush in the breast. Cases and controls will be compared for presence of Candida albicans in their breast milk, premature cessation of breastfeeding and confidence in their ability to breastfeed
Date of first enrolment: 01/04/2015
Target sample size: 75
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN88839993
Study type:  Observational
Study design:  Observational case-control study (Diagnostic)  
Phase: 
Countries of recruitment
Sweden
Contacts
Name: Kirsti    Kaski
Address:  BB-avdelning Helsingborg Hospital Charlotte Yhlens gata 10 25187 Helsingborg Sweden
Telephone: +46 (0)70 827 8604
Email: kirsti.kaski@skane.se
Affiliation: 
Name: Linda J.    Kvist
Address:  Lund University Medicinska fakultetet Baravägen 3 22100 Lund Sweden
Telephone: +46 (0)42 227 113
Email: linda.kvist@med.lu.se
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria for cases:
1. Breastfeeding woman
2. Adult, = 18 years
3. Exclusive or non-exclusive breastfeeding
4. Good understanding of Swedish language in spoken and written form
5. One or several symptoms on the nipple and areola or in the breast: red, extenuated, tender, burning, sloughing skin on the nipple and areola, with or without deep, radiating, cutting pain sensations in the breast

Inclusion criteria for the controls:
1. Breastfeeding woman
2. Adult, = 18 years
3. Exclusive or non-exclusive breastfeeding
4. Good understanding of Swedish language in spoken and written form
5. None of the symptoms on the nipple and areola or in the breast: red, extenuated, tender, burning, sloughing skin on the areola, with or without deep, radiating, cutting pain sensations in the breast

Exclusion criteria: 1. Breastfeeding women with pain, skin symptoms or sores which can be attributed to breastfeeding technical difficulties such as short frenulum, mastitis or Raynaud's syndrome
2. Women with excema-like skin conditions and white spot


Age minimum:
Age maximum:
Gender: Female
Health Condition(s) or Problem(s) studied
Candidosis of the breast during breastfeeding
Infections and Infestations
Candidosis of the breast during breastfeeding
Intervention(s)
Participants in the case group are informed about the study when they contact the breastfeeding clinic by telephone for symptoms associated with "thrush" infection in the breasts.
Participants in the control group get information about the study and are recruited at local baby-well clinics while they have the routine health control.

One consult appointment occasion with a breastfeeding consultant is booked for the participants in the case group, inclusive usual consult appointment according the breastfeeding clinic routine.

Participants in the case group are recruited at the breastfeeding clinic after receiving more information and given a written consent. A questionnaire is used to collect information about age, parity, age of the breastfed baby, history of previous candida infections, Diabetes (gestational or type 1), type of delivery, antibiotic treatment during and after delivery, breastfeeding level (exclusive/non-exclusive), pain location and severity (NAS) and breastfeeding efficacy. Breastmilk from the most painful breast is collected for culture for Candida albicans.

Participants in the control group meet the researcher once at the baby-well clinic direct after a health control. They receive more information about the study and give their written consent. The same questionnaire as with the cases is used and breastmilk is collected for culture for Candida albicans.

Participants in the case group receive four weekly telephone contacts from a breastfeeding consult in the breastfeeding clinic. A questionnaire is used to collect information about pain severity (NAS), breastfeeding success, changes in symptoms and medicine therapy. After four weeks of telephone contacts they receive a mail questionnaire with same questions monthly in three months.
The controls receive a mail questionnaire monthly in four months with questions about breastfeeding success and if they have had symptom or pain associated with thrush in the breasts.
Primary Outcome(s)
Presence of Candida albicans in breastmilk is measured using cultivation with Sabourad Agar or CROME Agar Candida at baseline
Secondary Outcome(s)
1. Breastfeeding efficacy in the breastfeeding mothers is measured by a validated breastfeeding instrument Breastfeeding Self Efficacy Scale- Short Form (BSES-SF) at baseline
2. Level of breastfeeding is measured by a questionnaire one month after the first contact with the researcher
Secondary ID(s)
2014/600
Source(s) of Monetary Support
Stig & Ragna Gorthon Foundation, Lions Research Foundation , Mjölkdroppen Association
Secondary Sponsor(s)
Mjölkdroppen Association
Lions Research Foundation, Skåne
Ethics review
Status:
Approval date:
Contact:
Central Ethical Review Board, Lund, Sweden, 16/09/2014 ref: 2014/600
Results
Results available: Yes
Date Posted:
Date Completed: 01/06/2017
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history